Local and systemic 20S proteasome release in patients with stenting of stenotic saphenous vein bypass grafts - A pilot study

Archives of Medical Science

Volumn 5, Issue 4, 2009, Pages 559-563

  Sixt, Stephan Urs ^a   Leineweber, Kirsten ^b   Böse, Dirk ^b   Konorza, Thomas ^b   Haude, Michael ^c   Hogrebe, Stephan ^a   Kleinbongard, Petra ^b   Erbel, Raimund ^b   Peters, Jürgen ^a   Heusch, Gerd ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c Lukaskrankenhaus Neuss ^*  (Germany)

Author keywords

Atherosclerosis; Percutaneous coronary intervention; Protection device

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTEASOME;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROTIC PLAQUE; CIRCULATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DEVICE; DISEASE COURSE; DRUG ELUTING STENT; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT FAILURE; HUMAN; IMPLANT; INTERVENTION STUDY; MALE; MOLECULAR WEIGHT; PILOT STUDY; PLASMA; PROTEIN SECRETION; RESTENOSIS; SAPHENOUS VEIN; SYMPTOM; VEIN GRAFT;

EID: 75349087738     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Herrmann J, Ciechanover A, Lerman LO, Lerman A. The ubiquitin-proteasome system in cardiovascular diseases - a hypothesis extended. Cardiovasc Res 2004; 61: 11-21.
2. Sixt SU, Dahlmann B. Extracellular, circulating proteasomes and ubiquitin - incidence and relevance. Biochim Biophys Acta 2008; 1782: 817-23.
3. Herrmann J, Edwards WD, Holmes DR Jr, et al. Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes. J Am Coll Cardiol 2002; 40: 1919-27.
4. Marfella R, Di Filippo C, Laieta MT, et al. Effects of ubiquitin-proteasome system deregulation on the vascular senescence and atherosclerosis process in elderly patients. J Gerontol A Biol Sci Med Sci 2008; 63: 200-3.
5. Marfella R, D'Amico M, Esposito K, et al. The ubiquitinproteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment. Diabetes 2006; 55: 622-32.
6. Leineweber K, Böse D, Vogelsang M, Haude M, Erbel R, Heusch G. Intense vasoconstriction in response to aspirate from stented saphenous vein aortocoronary bypass grafts. J Am Coll Cardiol 2006; 47: 981-6.
7. Campeau L. The Canadian Cardiovascular Society grading of angina pectoris revisited 30 years later. Can J Cardiol 2002; 18: 371-9.
8. Böse D, Leineweber K, Konorza T, et al. Release of TNF-alpha during stent implantation into saphenous vein aortocoronary bypass grafts and its relation to plaque extrusion and restenosis. Am J Physiol Heart Circ Physiol 2007; 292: H2295-9.
9. Sixt SU, Beiderlinden M, Jennissen HP, Peters J. Extracellular proteasome in the human alveolar space: a new housekeeping enzyme? Am J Physiol Lung Cell Mol Physiol 2007; 292: L1280-8.
10. Sixt SU, Adamzik M, Spyrka D, et al. Alveolar extracellular 20S proteasome in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2009; 179: 1098-106.
11. Grune T, Jung T, Merker K, Davies KJ. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. Int J Biochem Cell Biol 2004; 36: 2519-30.
12. Stoneman VE, Bennett MR. Role of apoptosis in atherosclerosis and its therapeutic implications. Clin Sci (Lond) 2004; 107: 343-54.
13. Versari D, Herrmann J, Gössl M, et al. Dysregulation of the ubiquitin-proteasome system in human carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2006; 26: 2132-9.
14. Erbel R, Heusch G. Brief review: coronary microembolization. J Am Coll Cardiol 2000; 36: 22-4.
15. Skyschally A, Leineweber K, Gres P, Haude M, Erbel R, Heusch G. Coronary microembolization. Basic Res Cardiol 2006; 101: 373-82.
16. Heusch P, Skyschally A, Leineweber K, Haude M, Erbel R, Heusch G. The interaction of coronary microembolization and ischemic preconditioning: a third window of cardioprotection through TNF-alpha. Arch Med Sci 2007; 2: 83-92.
17. Herrmann J, Haude M, Lerman A, et al. Abnormal coronary flow velocity reserve after coronary intervention is associated with cardiac marker elevation. Circulation 2001; 103: 2339-45.
18. Herrmann J, Lerman A, Baumgart D, et al. Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction. Circulation 2002; 106: 2180-3.
19. Bahrmann P, Werner GS, Heusch G, et al. Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris undergoing elective percutaneous coronary interventions. Circulation 2007; 115: 600-8.
20. Böse D, von Birgelen C, Zhou XY, et al. Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions. Basic Res Cardiol 2008; 103: 587-97.
21. Tan C, Li Y, Tan X, Pan H, Huang W. Inhibition of the ubiquitin-proteasome system: a new avenue for atherosclerosis. Clin Chem Lab Med 2006; 44: 1218-25.
22. Herrmann J, Lerman A, Baumgart D, et al. Pre-procedural statin medication reduces the extent of peri-procedural non-Q-wave myocardial infarction. Circulation 2002; 106: 2180-3.